-
Lumateperone, sold
under the
brand name Caplyta, is an
atypical antipsychotic medication of the
butyrophenone class. It is
approved for the
treatment of...
- Haloperidol, the most
widely used
classical antipsychotic drug in this
class Lumateperone, an
atypical antipsychotic used for
schizophrenia and
bipolar depression...
-
Levosulpiride –
approved in low
doses for
major depressive disorder Lumateperone (Caplyta) –
approved as a
monotherapy for
bipolar depression Lurasidone...
- ITI-1284) is an
experimental antipsychotic and
deuterated analogue of
lumateperone which is
under development as a
sublingually administered orally disintegrating...
- the FDA in the
United States. Cariprazine, Quetiapine, lurasidone, and
lumateperone have been approved, as monotherapies, for
bipolar depression, but as...
-
lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063
Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724
Adrafinil Aplindore...
- Levomepromazine, Lisdexamfetamine, Lithium, Lorazepam, Lorediplon, Loxapine,
Lumateperone,
Lurasidone Maprotiline, Melperone, Meprobamate, Mesoridazine, Methamphetamine...
-
lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063
Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724
Adrafinil Aplindore...
- of first-generation (typical) antipsychotics.
Lumateperone (Caplyta) – In
December 2019,
lumateperone, a
presynaptic D2
receptor partial agonist and...
-
Diphenylprolinol DMBMPP Ergolines (e.g., LSD) GYKI-52895 HDMP-29
Ivabradine Lumateperone and
analogues (e.g., IHCH-7079, IHCH-7086, IHCH-7113, ITI-1549) Methoxphenidine...
